Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
作者信息
Gevers S, Kwa M S G, Wijnans E, van Nieuwkoop C
机构信息
Dutch Medicines Evaluation Board, Utrecht, the Netherlands.
Dutch Medicines Evaluation Board, Utrecht, the Netherlands.
出版信息
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
Abstract
摘要
相似文献
1
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
2
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.
3
Chloroquine and hydroxychloroquine in covid-19.
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
4
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
PLoS Med. 2020 Sep 3;17(9):e1003252. doi: 10.1371/journal.pmed.1003252. eCollection 2020 Sep.
5
Of chloroquine and COVID-19.
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
6
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
Am J Ophthalmol. 2020 May;213:A3-A4. doi: 10.1016/j.ajo.2020.03.028. Epub 2020 Mar 25.
7
Chloroquine and its derivatives in the management of COVID-19: A scoping review.
Biomedica. 2020 Oct 30;40(Supl. 2):80-95. doi: 10.7705/biomedica.5478.
8
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
West J Emerg Med. 2020 Jun 3;21(4):760-763. doi: 10.5811/westjem.2020.5.47810.
9
Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
J Coll Physicians Surg Pak. 2020 Jun;30(6):78. doi: 10.29271/jcpsp.2020.Supp1.S78.
10
A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).
Am J Trop Med Hyg. 2020 May;102(5):932-933. doi: 10.4269/ajtmh.20-0230.
引用本文的文献
1
Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19.
Heliyon. 2024 Aug 28;10(17):e37098. doi: 10.1016/j.heliyon.2024.e37098. eCollection 2024 Sep 15.
2
Cyanobacterial and microalgae polymers: antiviral activity and applications.
Braz J Microbiol. 2024 Dec;55(4):3287-3301. doi: 10.1007/s42770-024-01452-5. Epub 2024 Jul 15.
3
Theoretical Investigation of the Green-Synthesized Carbon-Based Nanomaterial Potential as Inhibitors of ACE2 for Blocking SARS-CoV-2 Binding.
ACS Omega. 2024 Mar 27;9(14):16701-16715. doi: 10.1021/acsomega.4c00759. eCollection 2024 Apr 9.
4
A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.
Open Med (Wars). 2024 Mar 15;19(1):20230867. doi: 10.1515/med-2023-0867. eCollection 2024.
5
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.
Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8.
6
COVID-19 Therapeutic Potential of Natural Products.
Int J Mol Sci. 2023 May 31;24(11):9589. doi: 10.3390/ijms24119589.
7
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.
Front Pharmacol. 2023 Apr 12;14:1111329. doi: 10.3389/fphar.2023.1111329. eCollection 2023.
8
Adverse Drug Reactions during COVID-19 Treatment: A Comprehensive Analysis Focused on Hospitalized Patients, with the Use of a Survey in Cuba in 2020.
Adv Pharmacol Pharm Sci. 2023 Feb 1;2023:1995642. doi: 10.1155/2023/1995642. eCollection 2023.
9
Role of the Microbiome in the Pathogenesis of COVID-19.
Front Cell Infect Microbiol. 2022 Mar 31;12:736397. doi: 10.3389/fcimb.2022.736397. eCollection 2022.
10
Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine.
Front Pharmacol. 2022 Mar 23;13:812338. doi: 10.3389/fphar.2022.812338. eCollection 2022.
本文引用的文献
1
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
JAMA Cardiol. 2020 Sep 1;5(9):1036-1041. doi: 10.1001/jamacardio.2020.1834.
2
Clinical Characteristics of Covid-19 in New York City.
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
3
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.
JAMA Cardiol. 2020 Jul 1;5(7):751-753. doi: 10.1001/jamacardio.2020.1105.
4
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
5
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.
Clin Drug Investig. 2018 Aug;38(8):653-671. doi: 10.1007/s40261-018-0656-y.
6
Antimalarial drug toxicity: a review.
Drug Saf. 2004;27(1):25-61. doi: 10.2165/00002018-200427010-00003.
Zotero 插件